Delivery Order SPE2DB22D2007-SPE2DB24FH7RB
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Delivery Order with a Firm Fixed Price pricing type, a total ceiling value of $4,127.07, and a performance period that runs through December 28, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $18,732.80 and is a delivery order with a firm fixed price. The ultimate completion date is January 24, 2024. There is no set-aside designation for this contract, indicating it...
- This federal contract award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $12,160.25. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Defense Department's Medical Supply Chain agency. The $25,835.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a firm fixed-price delivery order with a ceiling value of $2,191.87 and an ultimate completion date of September 21, 2021. This award is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract has a ceiling value of $5,288.62 and an ultimate completion date of October 24, 2023. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and it is awarded under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc. This IDC,...
- The contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL to a U.S. government agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $6,381.92. The contract is a firm-fixed-price delivery order with a completion date of November 8, 2022. The contract does not have a set-aside designation, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of insulin aspart 100 unit/mL pens. The contract has a ceiling value of $9,277.12 and an ultimate completion date of February 12, 2024. It is a firm fixed-price delivery order contract and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract has a ceiling value of $9,296.70 and a period of performance ending on January 9, 2024. This award is issued as a delivery order against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a maximum potential value of $999,999,999.00 and...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $24,619.88 and was awarded on December 21, 2023, with a completion date of December 22, 2023. The contract is a Delivery...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH7RBDelivery Order
This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML pen with a 3ML volume. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a ceiling value of $13,689.98 and is a Firm Fixed Price Delivery Order contract. No set-aside designation was used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also includes a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 12/5/23 |